ArticleOncology letters2024

Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System.

Yu Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.